Auransa is fundamentally changing the way drugs are discovered for conditions like cancer and Alzheimer’s disease.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Palo Alto
State: California
Zip:
Country: United States
Auransa is an AI-driven platform for discovering drugs of novel pharmacology from vast amounts of genomics data collected from human disease tissues. The company&s;s platform is used to study molecular disease subtypes and predict compounds and targets for responder patient population. Current internal drug pipeline includes cancer and other diseases. The company has partnership with companies and institutions in biopharma industry.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|---|---|---|---|
8/2020 | Series A | 6 | $15.7M |
11.2 Capital AME Cloud Ventures DCVC Future Shape Lux Capital Neue Fund Harmonix Fund 11.2 Capital AME Cloud Ventures DCVC Future Shape Lux Capital Neue Fund |
3/2015 | Seed Round | 1 | $2.8M |
DCVC DCVC |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|